John Fluke Joins Novuson Surgical as New Board Member

BOTHELL, WA, USA, August 28, 2024 /EINPresswire.com/ -- Novuson Surgical, a leading innovator in surgical technology, is pleased to announce the appointment of John M. Fluke, Jr. to its Board of Directors. Mr. Fluke brings decades of management and corporate governance experience in the electronics manufacturing and biotechnology sectors. His addition to Novuson Surgical’s board marks a pivotal step in the company’s commitment to advancing surgical solutions and improving patient outcomes worldwide.

"We are thrilled to welcome John Fluke to our Board of Directors," said Stuart Mitchell, CEO of Novuson Surgical. "His deep understanding of the medical technology landscape, coupled with his proven track record of strategic leadership, will be invaluable as we continue to expand our portfolio of innovative surgical solutions. John’s insights will help us navigate the complexities of the healthcare market and drive our mission to enhance the quality of surgical care."

Mr. Fluke is currently an independent director of Athira Pharma, Inc. (2014-present: NASDAQ symbol ATHA, late development-stage https://www.athira.com) and has served as an independent of PACCAR Inc (1984-2014: NASDAQ symbol PCAR Fluke Corporation, FLUKE Corporation (1966-1998: NYSE symbol FLK https://www.fluke.com/en/where-to-buy/seasonal-promotions/75th-anniversary-promotion-meat-en acquired by Danaher, Inc. in 1998).

Mr. Fluke also serves as an independent director and senior business advisor to Matchstick Technologies, Inc. (2015-present: closely-held, operating-stage https://matchsticktechnologies.com) and Pluristyx, Inc. (2018-present: closely-held, operating-stage https://pluristyx.com) and has served an independent director of Precision Genome Engineering, Inc. (closely-held development stage, M&A exit 2014 https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-acquires-precision-genome-engineering-privately).

Mr. Fluke also served on the national boards and executive committees of The American Electronics Association (member 1984-1996) and National Association of Manufacturers (1986-1992), the University of Washington’s Washington Technology Center (chairman 1983-1986), Stanford University Engineering Advisory Board (member 1986-1990), Washington State China Relations Council (chairman1984-1987), University of Puget Sound (trustee 1987-2004).

"I am honored to join the Board of Novuson Surgical" said John Fluke. "I look forward to working with the talented team at Novuson as they bring these urgently needed surgical tools to market."

Novuson Surgical has been a pioneer in the development of advanced surgical technologies through ultrasound, with a focus on improving patient outcomes and enhancing the efficiency of surgical procedures. The addition of John Fluke to the board underscores the company’s dedication to attracting top-tier talent and expertise to guide its strategic direction.
For more information about Novuson Surgical and its innovative surgical solutions, please visit Novuson.com.

**About Novuson Surgical**

Novuson Surgical is a leading provider of advanced surgical technology solutions, committed to enhancing the quality and efficiency of surgical procedures through ultrasound technology. With a focus on innovation, the company develops state-of-the-art products that improve patient outcomes and support healthcare professionals in delivering exceptional care. Novuson Surgical's portfolio includes 5 new prototypes of surgical tools, and the company continues to push the boundaries of what is possible in the field of surgical technology.

Forward-Looking Statements.

This press release contains forward-looking statements that involve future events, our future performance and our expected future operations and actions. All statements that address expectations or projections about the future, including statements about product development, market position, expected expenditures and financial results, are forward-looking statements. Forward-looking statements can be identified by words like “expects,” “believes,” “anticipates,” “plans,” “intends,” “projects,” “indicates,” and similar expressions. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Accordingly, our actual results or performance may differ significantly, positively or negatively, from forward-looking statements made herein. Unanticipated events and circumstances are likely to occur. We undertake no obligation and are under no duty to update any forward-looking statements. We caution you not to put undue reliance on any forward-looking statements, which speak only as of the date of this press release.

Stuart Mitchell
Novuson Surgical Inc.
+1 4252386227
email us here
Visit us on social media:
LinkedIn